Vincenzo Atella

Atella, Vincenzo BW3x4

Vincenzo Atella, MSc

  • Associate Professor, Department of Economics and Finance - University of Roma
  • Director of the Centre for Economic and International Studies (CEIS) at the University of Rome “Tor Vergata”
  • Adjunct Affiliate at the Center for Health Policy and the Department of Medicine

Via Columbia 2
00133 Rome Italy

+39 06 7259 5606 (voice)
+39 06 2020687 (fax)


Vincenzo Atella is Associate Professor of Economics at the University of Rome "Tor Vergata" where he teaches Macroeconomics and courses in Applied Health Economics at graduate and post graduate level. He is also adjunct associate of the Center for Health Policy at Stanford where he has been visiting professor in different occasions.
Currently, he is CEIS Tor Vergata Director and Scientific Director of the Farmafactoring Foundation, member of SIVEAS (Health Care Services National Evaluation System) of the Ministry of Health, chief economist of the Italian Association of General Practitionners (Società Italiana di Medicina Generale – SIMG) and member and co-founder of the Italian Public Affair Association.

In the recent past he has been member of the International Committee of Experts advising IQWiG (the German Agency for Health Care) for setting national guidelines for Economic Evaluation and member of the Italian Committee for Drug Price appointed by the Ministry of Treasury. He also served as member of the “Strategic Evaluation Committee” of the Italian Drug Agency (AIFA), and has been consultant for the Italian Regional Agency for Health Care Services (, the National Institute of Health (, the WHO and the World Bank. Prof. Atella has been coordinator of a large European Research Network called TECH Europe ( which has received financial support by the European Science Foundation. His most recent research activity has focused on poverty, income distribution and health economics. In this last field his research deals with the introduction of new technologies in the health sector, the impact of different co-payment systems on pharmaceutical decision making by physicians and on drug consumption by patients, forecasting health expenditure and with health related income inequalities. The results of this research activity have been published on several international refereed journals as well books.


October 2010

The efficiency frontier approach to economic evaluation of health care interventions

cover link The efficiency frontier approach to economic evaluation of health care interventions